LINCOLN NATIONAL CORP - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 84 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$7,495
+37.1%
10,3400.0%0.00%
Q4 2022$5,465
-39.3%
10,3400.0%0.00%
Q3 2022$9,000
-18.2%
10,3400.0%0.00%
Q2 2022$11,000
-15.4%
10,3400.0%0.00%
Q1 2022$13,000
-23.5%
10,3400.0%0.00%
Q4 2021$17,000
-50.0%
10,3400.0%0.00%
-100.0%
Q3 2021$34,000
-47.7%
10,3400.0%0.00%0.0%
Q2 2021$65,000
+132.1%
10,340
-20.5%
0.00%0.0%
Q1 2021$28,00013,0000.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 362,072$453,0000.07%
GSA CAPITAL PARTNERS LLP 66,223$83,0000.01%
Aquatic Capital Management LLC 4,400$6,0000.01%
D. E. Shaw & Co., Inc. 3,863,135$4,829,0000.01%
Spire Wealth Management 94,000$118,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 111,898$140,0000.00%
Renaissance Technologies 2,100,492$2,626,0000.00%
ALPS ADVISORS INC 130,141$163,0000.00%
Cutler Group LLC / CA 21,400$30,0000.00%
TWO SIGMA ADVISERS, LP 681,600$852,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders